| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data
|
Bagante, Fabio
|
|
|
148 |
C |
p. 348-358
|
artikel
|
| 2 |
Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy
|
Michaelson-Cohen, Rachel
|
|
|
148 |
C |
p. 95-102
|
artikel
|
| 3 |
Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials
|
Agostinetto, Elisa
|
|
|
148 |
C |
p. 76-91
|
artikel
|
| 4 |
Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients
|
Campanale, Antonella
|
|
|
148 |
C |
p. 277-286
|
artikel
|
| 5 |
Corrigendum to “Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyˮ [Eur J Canc 144 (2021) 341–350]
|
Jeong, Jae Ho
|
|
|
148 |
C |
p. 451-452
|
artikel
|
| 6 |
Cribriform architecture prostatic adenocarcinoma in needle biopsies is a strong independent predictor for lymph node metastases in radical prostatectomy
|
Downes, Michelle R.
|
|
|
148 |
C |
p. 432-439
|
artikel
|
| 7 |
Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers
|
Shiihara, Masahiro
|
|
|
148 |
C |
p. 239-250
|
artikel
|
| 8 |
Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans
|
Khorrami, Mohammadhadi
|
|
|
148 |
C |
p. 146-158
|
artikel
|
| 9 |
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma
|
Liu, Dan
|
|
|
148 |
C |
p. 1-13
|
artikel
|
| 10 |
Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival
|
Chow, Ken
|
|
|
148 |
C |
p. 440-450
|
artikel
|
| 11 |
Editorial for Cribriform architecture prostatic adenocarcinoma in needle biopsy is a strong independent predictor for lymph node metastases in radical prostatectomy (M. Downes et al.) and Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival (K. Chow et al.)
|
Compérat, Eva
|
|
|
148 |
C |
p. 430-431
|
artikel
|
| 12 |
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism
|
Verso, Melina
|
|
|
148 |
C |
p. 371-381
|
artikel
|
| 13 |
Erratum to ‘Identification of nephronectin as a new target for IGF1 action’ [Eur J Canc 141 (2020) Pages 115–127]
|
Sarfstein, Rive
|
|
|
148 |
C |
p. 453-454
|
artikel
|
| 14 |
Exploring the resistance mechanisms of second-line osimertinib and their prognostic implications using next-generation sequencing in patients with non-small-cell lung cancer
|
Lee, Kyoungmin
|
|
|
148 |
C |
p. 202-210
|
artikel
|
| 15 |
Hypermutated tumours across 11 cancer types show three distinct immune subtypes
|
Hu, Wangxiong
|
|
|
148 |
C |
p. 230-238
|
artikel
|
| 16 |
Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer
|
Quintana, Ángela
|
|
|
148 |
C |
p. 134-145
|
artikel
|
| 17 |
Immune-related adverse events after a single dose of pembrolizumab
|
Vos, Hanne
|
|
|
148 |
C |
p. 92-94
|
artikel
|
| 18 |
Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests
|
van Dam, Peter
|
|
|
148 |
C |
p. 328-339
|
artikel
|
| 19 |
Intraperitoneal nivolumab in a patient with pancreatic cancer and refractory malignant ascites
|
Wang, Sing-Ting
|
|
|
148 |
C |
p. 48-50
|
artikel
|
| 20 |
Leptomeningeal disease from melanoma—Poor prognosis despite new therapeutic modalities
|
Chorti, Eleftheria
|
|
|
148 |
C |
p. 395-404
|
artikel
|
| 21 |
Longitudinal associations between exposure to anesthesia and neurocognitive functioning in pediatric medulloblastoma
|
Partanen, M.
|
|
|
148 |
C |
p. 103-111
|
artikel
|
| 22 |
Long-term impact of immunotherapy on quality of life of surviving patients: A multi-dimensional descriptive clinical study
|
Domnariu, Paul-Albert
|
|
|
148 |
C |
p. 211-214
|
artikel
|
| 23 |
Lost in application: Measuring hypoxia for radiotherapy optimisation
|
Thiruthaneeswaran, Niluja
|
|
|
148 |
C |
p. 260-276
|
artikel
|
| 24 |
Mainstreaming informed consent for genomic sequencing: A call for action
|
Bunnik, Eline M.
|
|
|
148 |
C |
p. 405-410
|
artikel
|
| 25 |
Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave
|
Indini, Alice
|
|
|
148 |
C |
p. 112-116
|
artikel
|
| 26 |
Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening
|
Houssami, Nehmat
|
|
|
148 |
C |
p. 14-23
|
artikel
|
| 27 |
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
|
Zaremba, Anne
|
|
|
148 |
C |
p. 340-347
|
artikel
|
| 28 |
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial
|
Cascinu, Stefano
|
|
|
148 |
C |
p. 422-429
|
artikel
|
| 29 |
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
|
Versluis, Judith M.
|
|
|
148 |
C |
p. 51-57
|
artikel
|
| 30 |
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
|
Knispel, Sarah
|
|
|
148 |
C |
p. 61-75
|
artikel
|
| 31 |
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
|
Rosati, Gerardo
|
|
|
148 |
C |
p. 190-201
|
artikel
|
| 32 |
Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway
|
Mao, Lili
|
|
|
148 |
C |
p. 297-306
|
artikel
|
| 33 |
Pembrolizumab plus eribulin in hormone-receptor–positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase Ⅱ trial
|
Pérez-García, José M.
|
|
|
148 |
C |
p. 382-394
|
artikel
|
| 34 |
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study
|
Cortellini, Alessio
|
|
|
148 |
C |
p. 24-35
|
artikel
|
| 35 |
Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors
|
Rogado, Jacobo
|
|
|
148 |
C |
p. 58-60
|
artikel
|
| 36 |
Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting
|
Francis, Katherine E.
|
|
|
148 |
C |
p. 251-259
|
artikel
|
| 37 |
Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
|
Kim, Youn H.
|
|
|
148 |
C |
p. 411-421
|
artikel
|
| 38 |
SARS-CoV-2 vaccines for cancer patients: a call to action
|
Corti, Chiara
|
|
|
148 |
C |
p. 316-327
|
artikel
|
| 39 |
SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)
|
Gauci, Marie-Léa
|
|
|
148 |
C |
p. 121-123
|
artikel
|
| 40 |
Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2)
|
Mathevet, Patrice
|
|
|
148 |
C |
p. 307-315
|
artikel
|
| 41 |
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study
|
Ladoire, Sylvain
|
|
|
148 |
C |
p. 359-370
|
artikel
|
| 42 |
STK11 alterations in the pan-cancer setting: prognostic and therapeutic implications
|
Krishnamurthy, Nithya
|
|
|
148 |
C |
p. 215-229
|
artikel
|
| 43 |
Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy
|
Groeneveld, Clarice S.
|
|
|
148 |
C |
p. 181-189
|
artikel
|
| 44 |
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials
|
Villegas, Sonia L.
|
|
|
148 |
C |
p. 159-170
|
artikel
|
| 45 |
Transplant rejections associated with immune checkpoint inhibitors: A pharmacovigilance study and systematic literature review
|
Nguyen, Lee S.
|
|
|
148 |
C |
p. 36-47
|
artikel
|
| 46 |
Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma
|
Hilmi, Marc
|
|
|
148 |
C |
p. 171-180
|
artikel
|
| 47 |
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D)
|
Moreno-Aspitia, Alvaro
|
|
|
148 |
C |
p. 287-296
|
artikel
|
| 48 |
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report
|
Seppälä, Toni T.
|
|
|
148 |
C |
p. 124-133
|
artikel
|
| 49 |
Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic
|
Matsuo, Koji
|
|
|
148 |
C |
p. 117-120
|
artikel
|
Tijdschrift beschrijving